A CLDN18.2‐Targeted Nanoplatform Manipulates Magnetic Hyperthermia Spatiotemporally for Synergistic Immunotherapy in Gastric Cancer

Abstract Precision treatment of gastric cancer requires specific biomarkers, and CLDN18.2 emerges as a promising target for patients’ stratification and therapeutic guidance. In 563 cases, 54.4% of patients are identified as CLDN18.2‐positive, with CLDN18.2 expression negatively correlated with immu...

Full description

Bibliographic Details

Published in:	Advanced Science
Main Authors:	Xueying Wang, Hui Hui, Jing Han, Ting Guo, Yiding Wang, Lin Meng, Cong Chen, Jie He, Xiaoyong Guo, Fuyu Zhong, Hong Du, Jie Tian, Xiaofang Xing, Yang Du, Jiafu Ji
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Subjects:	CLDN18.2 gastric cancer immunotherapy magnetic hyperthermia molecular imaging nanoparticle
Online Access:	https://doi.org/10.1002/advs.202413913